Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Emergent Biosolutions Inc. (EBS) had Tangible Shareholders Equity of $52.70M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$156.10M |
|
$6.80M |
|
$72.00M |
|
$84.10M |
|
$145.60M |
|
$10.50M |
|
$2.90M |
|
$13.40M |
|
$13.40M |
|
$6.80M |
|
$6.80M |
|
$6.80M |
|
$6.80M |
|
$10.50M |
|
$35.80M |
|
51.90M |
|
56.50M |
|
$0.13 |
|
$0.07 |
|
| Balance Sheet Financials | |
$637.60M |
|
$199.40M |
|
$682.80M |
|
$1.32B |
|
$148.70M |
|
$573.60M |
|
$648.60M |
|
$797.30M |
|
$523.10M |
|
|
Tangible Shareholders Equity |
$52.70M |
$523.10M |
|
51.80M |
|
| Cash Flow Statement Financials | |
$-33.80M |
|
$-2.40M |
|
$-11.40M |
|
$209.10M |
|
$161.50M |
|
$-47.60M |
|
$1.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.29 |
|
-- |
|
-- |
|
0.52 |
|
1.10 |
|
53.88% |
|
6.73% |
|
6.73% |
|
-- |
|
8.58% |
|
4.36% |
|
$-36.20M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.22 |
|
1.28 |
|
70.11 |
|
1.30% |
|
12.90% |
|
0.52% |
|
0.62% |
|
$10.10 |
|
$-0.64 |
|
$-0.60 |
|